Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 09:00PM GMT
Release Date Price: €66.06 (+0.09%)
Robert Adam Hopkins
BofA Securities, Research Division - MD of Equity Research

Okay. Thank you, everybody, for joining us for the next fireside chat as part of the virtual biggest Bank of America Healthcare Conference. We appreciate everybody being here this afternoon.

Very happy to have the senior leadership team from Tandem Diabetes Care on the line with us today, including John Sheridan and Leigh Vosseller and Susan Morrison. I'm going to hand it over to John for a presentation. And then we'll have some Q&A at the end. And just again, on behalf of BofA, thank you very much for your participation today.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks, Bob. It's great to see you, and welcome, everybody. So I'm on Slide 1 right now, and I just wanted to say that we had a great start to 2021. Clearly, our first quarter was -- it was really extraordinary. And we can move to Slide 3.

And when you think about Q1, a couple of really important highlights. First of all, we saw significant growth in pump

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot